Adv Exp Med Biol 2008, 617:359–366.PubMedCrossRef 9. Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H, Suzuki K: Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population. Int Urol Nephrol 2008, 40:947–951.PubMedCrossRef 10. Zheng
LZ, Wang YF, Schabath MB, Grossman HB, Wu XF: Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study. Cancer Lett 2003, 202:61–69.PubMedCrossRef 11. Kotnis A, Kannan S, Sarin R, Mulherkar R: Case-control study and meta-analysis of SULT1A1 Arg213His CHIR98014 order polymorphism for gene, ethnicity and environment interaction for cancer risk. Br J Cancer 2008, 99:1340–1347.PubMedCrossRef 12. Wang Z, Fu Y, Tang C, Lu S, Chu WM: SULT1A1 R213 H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls. Breast Cancer Res Treat 2010,122(1):193–8. buy AZD2171 Epub 2009 Dec 1PubMedCrossRef 13. Li H, Ha TC, Tai BC: XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast 2009, 18:183–191.PubMedCrossRef
14. Gulyaeva LF, Histone Methyltransferase inhibitor Mikhailova ON, PustyInyak VO, Kim IV, Gerasimov AV, Krasilnikov SE, Filipenko ML, Pechkovsky EV: Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, O-methylated flavonoid and breast
cancers in Novosibirsk, Russia. Adv Exp Med Biol 2008, 617:359–366.PubMedCrossRef 15. Rebbeck TR, Troxel AB, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Norman S, Bunin G, DeMichele A, Berlin M, Schinnar R, Berlin JA, Strom BL: Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiol Biomarkers Prev 2007, 16:444–450.PubMedCrossRef 16. Mikhailova ON, Gulyaeva LF, Prudnikov AV, Gerasimov AV, Krasilnikov SE: Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk. Pharmacogenomics Journal 2006, 6:189–193.PubMedCrossRef 17. Yang G, Gao YT, Cai QY, Shu XO, Cheng JR, Zheng W: Modifying effects of sulfotransferase 1A1 gene polymorphism on the association of breast cancer risk with body mass index or endogenous steroid hormones. Breast Cancer Res Tr 2005, 94:63–70.CrossRef 18. Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A: Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenet Genom 2005, 15:749–752.CrossRef 19. Lilla C, Risch A, Kropp S, Chang-Claude J: SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study. Breast Cancer Res 2005, 7:R229–237.PubMedCrossRef 20.